Press Releases
REVEALED: Alaska Governor Funded Group that Aimed to Sow Division Amongst Indigenous Groups
Accountable.US investigation reveals that Alaska Governor Dunleavy wrote seven figure check to advocacy group after reviewing their plans to undermine indigenous groups that oppose drilling the Arctic.
Press Releases
RealPage-Linked Corporate Landlords Continue to See High Earnings Amid Needless Rent Hikes
This week, corporate landlord companies American Homes 4 Rent, Equity Residential, and Essex Property Trust announced $354.6 million in combined Q3 2024 earnings.
Press Releases
Merck, BMS Rake in Billions as Big Pharma Continues Price-Gouging Campaign
Today, pharmaceutical leaders Merck and Bristol Myers Squibb (BMS) each reported their Q3 2024 earnings, with results reaching $3.2 and $1.2 billion, respectively. Both companies manufacture drugs selected for the Biden-Harris administration’s historic Medicare price negotiation program and are actively pursuing legal action to halt the program’s i
Press Releases
Visa, Mastercard Continue to Reap the Benefits of Duopoly Power at Small Business’ Expense
This week, credit card giants Visa and Mastercard reported quarterly earnings, with Visa seeing its net income for Q4 and full-year 2024 increasing 14% each, while Mastercard reported its Q3 net income increasing to $3.3 billion.
Press Releases
Watchdog: Big Pharma Back in Court Defending “Right” to Price Gouge Seniors
Today, AstraZeneca, Bristol Myers Squibb and Janssen will deliver opening arguments before the Third Circuit Court of Appeals for their case against the Biden-Harris administration’s historic Medicare negotiation program. Since President Biden signed the Inflation Reduction Act into law, the pharmaceutical industry has filed at least 9 lawsuits
Press Releases
Novartis Doubles Profits While Suing to Block Biden-Harris Rx Drug Negotiation Program Lowering Seniors’ Costs
Today, Novartis—one of several pharmaceutical companies still suing the Biden-Harris administration to block Medicare from negotiating lower prescription drug prices—announced $3.2 billion in Q3 2024 earnings, a 111% increase from 2023, thanks to “sales growth driven by continued strong performance from Entresto.”
Press Releases
Analysis: Amid DOT Rulemaking, Airline Industry Spent $26M to Keep Junk Fees Hidden
Today, the Biden-Harris administration revealed its final rule requiring airlines to be more transparent about pricing and to provide automatic cash refunds to customers with delayed or canceled flights. Alongside the announcement, new research from government watchdog Accountable.US revealed today that Airlines for America, a trade group, and six
Press Releases
Report: As Project 2025 Vows to Privatize Medicare, UnitedHealth Disproportionately Relies on Medicare Advantage for Profits
Today, a new report from government watchdog Accountable.US revealed that UnitedHealthcare disproportionately relied on a small number of Medicare Advantage beneficiaries for 46% of its $281 billion 2023 revenue.